{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:59:25Z","timestamp":1790189965795,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study aims to systematically assess the efficacy of Zhizi Qinggan Decoction combined with methimidazole tablets for the treatment of hyperthyroidism through a systematic review and meta-analysis, to provide evidence for clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A computer search of both Chinese and English databases, including CNKI, WangFang, VIP, CBM, PubMed, Cochrane Library, Embase, and Web of Science, was conducted. The search period was from the establishment of the database to August 2024. Randomized controlled trials (RCTs) related to the treatment of hyperthyroidism with Zhizi Qinggan Decoction were collected. Two independent researchers conducted the literature search, selection, and quality assessment. A meta-analysis was conducted using Stata 14.0 software to evaluate various outcome indicators, including thyroid hormone levels, clinical effectiveness, and traditional Chinese medicine syndrome scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 16 RCTs were included, involving 1320 patients with hyperthyroidism with an average age of 39.3 years. The meta-analysis results indicated that Zhizi Qinggan Decoction combined with Western medicine significantly improved outcomes in the treatment of hyperthyroidism compared to Western medicine alone. Specifically, the results for free triiodothyronine (standardized mean difference [SMD] = \u20130.79; 95% confidence interval [CI]: \u20131.11, \u20130.47;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), free thyroxine (SMD = \u20132.09; 95% CI: \u20132.91, \u20131.28;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), thyroid-stimulating hormone (SMD = 1.99; 95% CI: 1.00, 2.99;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), thyroid volume (SMD = \u20131.22; 95% CI: \u20131.84, \u20130.60;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), clinical efficacy (odds ratio = 6.05; 95% CI: 3.85, 9.51;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), adverse reactions (odds ratio = 2.61; 95% CI: 1.52, 4.45;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and traditional Chinese medicine syndrome score (SMD = \u20131.85; 95% CI: \u20132.41, \u20131.28;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) all showed statistically significant improvements (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Current evidence suggests that the combination of Zhizi Qinggan Decoction and methimazole tablets provides good clinical therapeutic outcomes. However, further efforts are needed to strengthen the evidence supporting its clinical application through rigorous large-sample RCTs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044483","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:59Z","timestamp":1757970059000},"page":"e44483","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The effect of Zhizi Qinggan decoction in treating hyperthyroidism: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[{"name":"Discipline Inspection Commission Office, The Third Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3184-596X","authenticated-orcid":false,"given":"Jiashuai","family":"Chu","sequence":"additional","affiliation":[{"name":"Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xiu","sequence":"additional","affiliation":[{"name":"Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[{"name":"Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000541255","article-title":"Successful maintenance treatment of a patient with resistant hyperthyroidism with traditional Persian medicine recommendations: a case report and literature review.","volume":"31","author":"Parvizi","year":"2024","journal-title":"Complement Med Res"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"1411629","DOI":"10.3389\/fendo.2024.1411629","article-title":"Causal association between hyperthyroidism and risk of gastroesophageal reflux or esophageal cancer: a bidirectional Mendelian randomization investigation.","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"20420188231158163","DOI":"10.1177\/20420188231158163","article-title":"The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic-pituitary-thyroid axis.","volume":"14","author":"Hoermann","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.3390\/ma7064669","article-title":"Nanomaterial-based electrochemical immunosensors for clinically significant biomarkers.","volume":"7","author":"Ronkainen","year":"2014","journal-title":"Materials (Basel)"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","article-title":"Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.","volume":"11","author":"Wiersinga","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"91","DOI":"10.17925\/EE.2024.20.2.12","article-title":"Prevalence and risk factors of heart failure in patients diagnosed with hyperthyroidism: a systematic review and meta-analysis.","volume":"20","author":"Fan","year":"2024","journal-title":"touchREV Endocrinol"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"1431686","DOI":"10.3389\/fimmu.2024.1431686","article-title":"Effect of methimazole treatment on Th1, Th17, and Th22 lymphocytes in pediatric Graves\u2019 disease patients.","volume":"15","author":"Starosz","year":"2024","journal-title":"Front Immunol"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40618-015-0391-7","article-title":"Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.","volume":"39","author":"Knobel","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41574-024-01016-5","article-title":"Graves disease: latest understanding of pathogenesis and treatment options.","volume":"20","author":"Lanzolla","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"R10-20260923","first-page":"29","article-title":"Current and emerging treatment options for Graves\u2019 hyperthyroidism.","volume":"6","author":"Abraham","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"R11-20260923","doi-asserted-by":"crossref","first-page":"1234056","DOI":"10.3389\/fendo.2023.1234056","article-title":"Preoperative preparation for Graves\u2019 disease.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"115075","DOI":"10.1016\/j.jep.2022.115075","article-title":"Research progress in the treatment of slow transit constipation by traditional Chinese medicine.","volume":"290","author":"Wang","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"R13-20260923","first-page":"99","article-title":"Director Wang Zhigang\u2019s experience in treating subacute thyroiditis with the \u201cliver fire\u201d theory.","volume":"15","author":"Yang","year":"2023","journal-title":"Chin J Clin Med"},{"key":"R14-20260923","first-page":"491","article-title":"Modern research progress in Traditional Chinese Medicine for thyroid nodules (goiter).","volume":"23","author":"Cao","year":"2022","journal-title":"J Shanxi Univ Tradit Chin Med"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"1438821","DOI":"10.3389\/fendo.2024.1438821","article-title":"Integrating network pharmacology, molecular docking and non-targeted serum metabolomics to illustrate pharmacodynamic ingredients and pharmacologic mechanism of Haizao Yuhu Decoction in treating hyperthyroidism.","volume":"15","author":"Huang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260923","first-page":"1","article-title":"Saikosaponin-d attenuates Hashimoto\u2019s thyroiditis by regulating macrophage polarization.","volume":"2022","author":"Du","year":"2022","journal-title":"J Immunol Res"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"1024693","DOI":"10.1155\/2022\/1024693","article-title":"Antidepressant active components of Bupleurum chinense DC-Paeonia lactiflora pall Herb pair: pharmacological mechanisms.","volume":"2022","author":"Lv","year":"2022","journal-title":"Biomed Res Int"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.18632\/aging.102998","article-title":"Correction for: ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice.","volume":"12","author":"Zhu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"2619695","DOI":"10.1155\/2017\/2619695","article-title":"Efficacy of once daily versus divided daily administration of low daily dosage (15\u2009mg\/day) of Methimazole in the induction of euthyroidism in Graves\u2019 hyperthyroidism: a randomized controlled study.","volume":"2017","author":"Sriussadaporn","year":"2017","journal-title":"Int J Endocrinol"},{"key":"R20-20260923","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"issue":"S2","key":"R21-20260923","first-page":"56","article-title":"A meta-analysis of the efficacy and safety of active calcium combined with alendronate sodium for treating hyperthyroid-induced osteoporosis.","volume":"23","author":"Wu","year":"2020","journal-title":"Chin J General Med"},{"key":"R22-20260923","first-page":"59","article-title":"Clinical observation of Zhizi Qinggan decoction for treating hyperthyroidism with excess liver fire syndrome.","volume":"36","author":"Zhang","year":"2017","journal-title":"Inner Mongolia J Tradit Chin Med"},{"key":"R23-20260923","first-page":"81","article-title":"Efficacy observation of Zhizi Qinggan decoction combined with methimazole in treating hyperthyroidism.","volume":"35","author":"Yue","year":"2016","journal-title":"Inner Mongolia J Tradit Chin Med"},{"key":"R24-20260923","first-page":"315","article-title":"Experience with Zhizi Qinggan decoction modified combined with methimazole tablets for treating primary hyperthyroidism.","volume":"9","author":"Zhang","year":"2018","journal-title":"Health Care Guide"},{"key":"R25-20260923","first-page":"144","article-title":"Observation of the effect of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"32","author":"Liu","year":"2016","journal-title":"Pract J Tradit Chin Med"},{"key":"R26-20260923","first-page":"119","article-title":"Observation of the effect of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"10","author":"Chen","year":"2016","journal-title":"Mod Appl Drugs China"},{"key":"R27-20260923","first-page":"72","article-title":"Analysis of the effect of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"37","author":"Feng","year":"2018","journal-title":"Inner Mongolia J Tradit Chin Med"},{"key":"R28-20260923","first-page":"3810","article-title":"Clinical observation of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"34","author":"Liu","year":"2019","journal-title":"Bright Tradit Chin Med"},{"key":"R29-20260923","first-page":"79","article-title":"Observation of the efficacy of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"7","author":"Han","year":"2021","journal-title":"Diet Health"},{"key":"R30-20260923","first-page":"78","article-title":"Clinical efficacy and safety of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"16","author":"Xie","year":"2023","journal-title":"Clin Ration Drug Use"},{"key":"R31-20260923","first-page":"15","article-title":"Efficacy analysis of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"7","author":"Cui","year":"2021","journal-title":"Health Essent"},{"key":"R32-20260923","first-page":"8","article-title":"Clinical study of modified Zhizi Qinggan decoction combined with methimazole in treating hyperthyroidism.","volume":"55","author":"Wang","year":"2023","journal-title":"New Tradit Chin Med"},{"key":"R33-20260923","first-page":"65","article-title":"Clinical effect analysis of Qinggan decoction combined with methimazole in treating hyperthyroidism.","volume":"40","author":"Shi","year":"2024","journal-title":"Chin Commun Phys"},{"key":"R34-20260923","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fmed.2020.00088","article-title":"Observation of the effect of modified Zhizi Qinggan decoction in treating newly diagnosed hyperthyroidism.","volume":"7","author":"Wang","year":"2014","journal-title":"Front Med"},{"key":"R35-20260923","first-page":"228","article-title":"Evaluation of the effect of modified Zhizi Qinggan decoction and methimazole tablets in treating primary hyperthyroidism.","volume":"21","author":"Zhang","year":"2021","journal-title":"World Latest Med Inform Dig"},{"key":"R36-20260923","first-page":"145","article-title":"Effect of modified Zhizi Qinggan decoction and methimazole tablets combined therapy in patients with primary hyperthyroidism.","volume":"6","author":"Li","year":"2021","journal-title":"Scientific Health"},{"key":"R37-20260923","first-page":"163","article-title":"Clinical efficacy observation of modified Zhizi Qinggan decoction combined with methimazole tablets in treating primary hyperthyroidism.","volume":"21","author":"Wang","year":"2021","journal-title":"World Latest Med Inform Dig"},{"key":"R38-20260923","first-page":"58","article-title":"Overview and prospect of Traditional Chinese medicine in treating hyperthyroidism.","volume":"38","author":"Jin","year":"2024","journal-title":"J Pract Tradit Chin Med"},{"key":"R39-20260923","doi-asserted-by":"crossref","first-page":"e33072","DOI":"10.1016\/j.heliyon.2024.e33072","article-title":"Transcriptomic and proteomic investigations identify PI3K-akt pathway targets for hyperthyroidism management in rats via polar iridoids from radix Scrophularia.","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"R40-20260923","doi-asserted-by":"crossref","first-page":"124140","DOI":"10.1016\/j.ijbiomac.2023.124140","article-title":"Effect of a polyherbal formulation on L-thyroxine induced hyperthyroidism in a rat model: in vitro and in vivo analysis and identification of bioactive phytochemicals.","volume":"237","author":"Samy","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"R41-20260923","doi-asserted-by":"crossref","first-page":"e263092","DOI":"10.1590\/1519-6984.263092","article-title":"Physiological and transcriptomic analyses of leaves from Gardenia jasminoides Ellis under waterlogging stress.","volume":"84","author":"Feng","year":"2022","journal-title":"Braz J Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:34Z","timestamp":1790186494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":41,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044483","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"2025-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}